Clinical Significance of Pharmacogenetic Profiling in Akathisia Associated With Obsessive-Compulsive Disorder

Obsessive-compulsive disorder (OCD) involves involuntary, distressing thoughts and compulsive behaviors. While selective serotonin reuptake inhibitors (SSRIs) are widely used in the treatment of OCD, when administered concomitantly with antipsychotics, they can contribute to akathisia. Drug metabolism and side-effect profiles can be influenced by genetic variations in genes encoding cytochrome P450 (CYP450) enzymes. In this case report, the pharmacogenetic findings and clinical features of a 29-year-old male patient diagnosed with OCD and experiencing akathisia were evaluated. The patient received standard pharmacotherapy prior to the genetic test. However, pharmacogenetic analysis revealed that the patient was an intermediate metabolizer (IM) for CYP2D6, a normal (extensive) metabolizer for other CYP enzymes, and showed increased induction for CYP1A2. Despite beta-blocker therapy, akathisia persisted and subsided following the readjustment of the quetiapine dose. However, the simultaneous use of multiple psychotropic drugs, dose changes, and potential drug-drug interactions limited the interpretation of the pharmacogenetic findings. This case report highlights the potential role of pharmacogenetic tests in clinical practice, but demonstrates that they do not definitively predict treatment response or adverse effects. Larger studies are needed to determine the clinical utility of pharmacogenetic testing in the management of OCD.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2026-11-17
DOI
https://doi.org/10.7759/cureus.119830
Primary Topic
Pharmacogenetics and Drug Metabolism
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Clinical Significance of Pharmacogenetic Profiling in Akathisia Associated With Obsessive-Compulsive Disorder

Nevzat Tarhan, Tayfun Gözler, Korkut Ulucan, Parvin Abdullayev
Cureus
Pharmacogenetics and Drug Metabolism
article

Clinical Significance of Pharmacogenetic Profiling in Akathisia Associated With Obsessive-Compulsive Disorder

Nevzat Tarhan, Tayfun Gözler, Korkut Ulucan, Parvin Abdullayev
article en

Abstract

Obsessive-compulsive disorder (OCD) involves involuntary, distressing thoughts and compulsive behaviors. While selective serotonin reuptake inhibitors (SSRIs) are widely used in the treatment of OCD, when administered concomitantly with antipsychotics, they can contribute to akathisia. Drug metabolism and side-effect profiles can be influenced by genetic variations in genes encoding cytochrome P450 (CYP450) enzymes. In this case report, the pharmacogenetic findings and clinical features of a 29-year-old male patient diagnosed with OCD and experiencing akathisia were evaluated. The patient received standard pharmacotherapy prior to the genetic test. However, pharmacogenetic analysis revealed that the patient was an intermediate metabolizer (IM) for CYP2D6, a normal (extensive) metabolizer for other CYP enzymes, and showed increased induction for CYP1A2. Despite beta-blocker therapy, akathisia persisted and subsided following the readjustment of the quetiapine dose. However, the simultaneous use of multiple psychotropic drugs, dose changes, and potential drug-drug interactions limited the interpretation of the pharmacogenetic findings. This case report highlights the potential role of pharmacogenetic tests in clinical practice, but demonstrates that they do not definitively predict treatment response or adverse effects. Larger studies are needed to determine the clinical utility of pharmacogenetic testing in the management of OCD.

Cureus
Üsküdar University (TR), HUN-REN Institute of Experimental Medicine (HU), Marmara University (TR)
Good health and well-being
Pharmacogenetics and Drug Metabolism
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon